QBIC II
VC Fund
QBIC II is a VC fund focused on Biotechnology and Industrial. QBIC II
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries QBIC II invests in
Stages QBIC II invests in
Countries QBIC II invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series B
- $22M–$64M
- Venture - Series Unknown
- $1.5M–$51M
Investment Focus
Industry
- Biotechnology 3 (30%)
- Industrial 2 (20%)
- Construction 2 (20%)
- Pharmaceutical 2 (20%)
- Solar 1 (10%)
Stage
- Series B 3 (30%)
- Venture - Series Unknown 3 (30%)
- Seed 1 (10%)
- Series A 1 (10%)
- Funding Round 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Sofie Baeten
Managing Partner
|
Managing Partner | Total investments: 7 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MRM Health NV, is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome. MRM Health was incorporated early 2020 by MRM Technologies, a Center of Expertise for microbiome research based in the biotech cluster in Ghent, in a joint venture with the Flemish Institute ofBiotechnology (VIB), an excellence-based entrepreneurial life sciences research institute in Flanders, Belgium, that focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications. | $64.1M / Series B / Sep 04, 2025 | ||
| EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology. EyeD Pharma focuses on the treatment of glaucoma. Traditionally, glaucoma is treated by administering eye drops every day for the rest of the patient’s life. | $51M / Venture - Series Unknown / Dec 24, 2021 | ||
| Sentea makes fibre optic Sensing affordable to the industry and enables continuous monitoring even in harsh environments. | $2.5M / Oct 07, 2021 | ||
| Sentea makes fibre optic Sensing affordable to the industry and enables continuous monitoring even in harsh environments. | $2.7M / Seed / Oct 07, 2021 | ||
| Aphea.Bio will develop next generation ‘biopesticides’ based on natural microorganisms. These products will provide an alternative for chemical pesticides, which are currently under serious pressure. In addition, the company will develop novel ‘biostimulants’, i.e. microorganisms that stimulate crop growth, for example through promoting the uptakeof nutrients from the soil. | $21.6M / Series B / Apr 14, 2021 | ||
| Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology thatrevolutionized the Internet during the last decades and now aims at transforming diabetes management. | $44.7M / Series B / Jul 27, 2020 | ||
| EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology. EyeD Pharma focuses on the treatment of glaucoma. Traditionally, glaucoma is treated by administering eye drops every day for the rest of the patient’s life. | $31.3M / Venture - Series Unknown / May 20, 2019 | ||
| In a world where only a small portion of our water is suitable for consumption, groundwater plays a crucial role. Sustainable groundwater management is essential to secure reliable drinking water supplies and protect the environment. Our goal is to confront the growing crisis of water scarcity head-on. iFLUX brings visibility to groundwaterdynamics, enabling insights for evidence-based groundwater management. We help manage complex groundwater challenges for cities, conservation and nature parks, the remediation and construction industries, and drinking water utilities.We have designed patented groundwater sampling technology (iFLUX Samplers) to track groundwater contamination. The iFLUX Samplers enable faster and more cost-efficient remediation projects, by measuring groundwater and contaminant movement over time. Groundwater and mass flux results provide soil experts with the key insights they need to reduce the risk and uncertainty of soil contamination management.iFLUX Sensing Solutions combine leading commercial sensors and external data with unique vertical and horizontal flux sensors, creating the most effective real-time digital monitoring networks. These groundwater monitoring networks translate secured data into concrete, real-time insights on a personalized dashboard. Public and company-specific data can be easily integrated into the dashboard, making it possible to analyze and interpret data, resulting in actionable insights. This real-time continuous and accurate data flow allows the immediate detection of the influence of groundwater-related activities and trends.iFLUX was founded in 2017 and is based on the research of Dr. Goedele Verreydt, a postdoctoral researcher at the University of Antwerp and VITO (Flemish Institute for Technological Research). | $1.5M / Venture - Series Unknown / May 09, 2019 | ||
| Aloxy provides an industrial internet of things solution for monitoring manual valve position in the industry. The company's services include valve position monitoring, emergency showers, line blinds, device management, network monitoring, and data integrity. Aloxy provides dependable industrial Internet of Things solutions designed to meetthe demands of the process industries, including chemical, oil, and gas, and others. | $2.3M / Series A / Sep 07, 2018 | ||
| The LAMWEC project is made up of a consortium of ocean energy experts. The consortium is led by Laminaria, and includes EMEC, Innosea, Ghent University, and TTI Testing. | $2.4M / Venture - Series Unknown / Sep 05, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does QBIC II invest in?
QBIC II invests primarily in Biotechnology, Industrial and Construction startups, most often at Series B and Venture - Series Unknown stage. Most of the 10 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is QBIC II's check size?
QBIC II typically joins rounds of $22M–$64M at Series B and $1.5M–$51M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds QBIC II participates in.
How do I contact QBIC II?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at QBIC II?
The team at QBIC II includes Sofie Baeten (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
